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Mario Jorge Garcia, MDSEE PAGE 1202T he most common valvular lesion seen in theU.S. adult population, aortic stenosis (AS)exhibits an estimated prevalence of 20% in
those >80 years of age (1). Degenerative aortic valve
calciﬁcation (AVC) is the most common cause of AS,
accounting for 82% of cases (2). In clinical practice,
the diagnosis of AS and the estimation of AS severity
rely primarily on echocardiography. Whereas 2-
and 3-dimensional echocardiography allow for the
anatomical evaluation of leaﬂet morphology and
left ventricular (LV) size, mass, and function,
Doppler echocardiography provides physiological
assessment of AS severity and has largely eliminated
the need for invasive hemodynamic studies (3).
The prognostic signiﬁcance of high aortic Doppler
velocities/high gradients has been reported in large
series of patients with longitudinal follow-up (4–6)
and has been incorporated into the American
College of Cardiology/American Heart Association
guidelines (7).
Nonetheless, although a velocity >4.0 m/s is highly
speciﬁc for severe AS, it lacks sensitivity (4) because
transvalvular velocities/gradients are ﬂow dependent
and may be reduced in patients with severe AS and
low cardiac output. Estimation of the aortic valve area
may also be inaccurate due to variations in the
anatomical shape of the outﬂow tract, misplacement
of the Doppler sample volume, and/or misalignment
with ﬂow direction. Moreover, the effective oriﬁce
area calculated by continuity is also ﬂow dependent
(8), leading to potential underestimation of valve area
in patients with low ﬂow.*Editorials published in the Journal of the American College of Cardiology
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in Pﬁzer Inc.The detection of severe leaﬂet calciﬁcation, in
addition to increased aortic velocity, by echocardio-
graphy has been associated with adverse outcomes
(5), but leaﬂet calciﬁcation is hard to quantify due to
the variable attenuation that dense calciﬁcation pro-
duces on the ultrasound beam. Attenuation is quan-
tiﬁable and reproducible on x-ray, unlike ultrasound,
and x-ray has been extensively validated for the
assessment of coronary artery calciﬁcation using
electrocardiography-gated computed tomography
(CT). The reproducibility of measurements of AVC by
CT has been previously demonstrated, as have its
correlations with histology and the hemodynamic
severity of AS (9). Severe AVC by CT has also been
associated with more rapid stenosis progression (10)
and increased short-term adverse clinical outcomes
in patients with asymptomatic AS (11).In this issue of the Journal, Clavel et al. (12)
examine the role of AVC as an independent predic-
tor of mortality in a large cohort of patients with AS.
In their study, both AVC and AVC density indepen-
dently predicted mortality with medical management
after adjustment for age, sex, symptoms, coronary
artery disease, diabetes, LV ejection fraction, and
echocardiographic indices of hemodynamic severity.
The addition of AVC increased the correct classiﬁca-
tion of high versus low risk by 12.5%. Moreover,
among patients with severe AVC, surgery conveyed a
survival advantage over medical therapy. These novel
results demonstrate the additional prognostic value
of CT over the echocardiographic indices accepted by
established guidelines. Given the high reproduc-
ibility, relatively low cost, and potentially important
additional information obtained by noncontrast
electrocardiography-gated CT, such as coronary cal-
cium score and extent of aortic root calciﬁcation, this
test would seem to provide high beneﬁt–cost and
beneﬁt–risk ratios.
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1215Further studies will be needed, however, before we
can determine when and how we should rely on CT
for clinical decision making. The patient cohort in the
study by Clavel et al. (12) represents a selected group
that underwent both echocardiography and CT.
Whereas clinical guidelines clearly deﬁne the in-
dications for performing echocardiographic studies,
the criteria that may have been used for performing
CT are unclear, thereby potentially introducing a se-
lection bias that may limit the wider applicability of
the study results.
Whereas the roles of inﬂammation and oxidative
stress in the genesis of AS have been largely
established (13), we also ﬁnd calciﬁc AS in numerous
conditions with increased calcium turnover, such as
Paget disease and end-stage renal disease. Renal
disease has been recognized as an important deter-
minant of outcomes in patients with AS undergoing
valve implantation (14) and, more recently, trans-
catheter aortic valve implantation (15). It is unclear
whether high AVC may be a manifestation of impaired
renal function in many of these patients and would
remain an independent prognostic factor after
adjustment for serum creatinine.
Patients with AS develop concentric LV hyper-
trophy as an adaptive mechanism to normalize wall
stress of the pressure-overloaded ventricle. In these
patients, the severity of diastolic dysfunction has an
important impact on long-term mortality after aortic
valve implantation (16). The prevalence of severe
pulmonary hypertension in patients with severeaortic valve stenosis has been reported to be 19% to
29% in patients undergoing preoperative invasive
hemodynamic evaluation, and severe pulmonary
hypertension is also associated with increased peri-
operative mortality (17). The inclusion of these
additional indices, which are routinely obtained
on transthoracic echocardiography, could limit the
added prognostic utility of AVC.
Finally, whereas the present study demonstrates
that in this selected cohort, aortic valve implantation
conveyed a survival advantage over medical therapy,
primarily in those patients with increased AVC, one
may not conclude that increased AVC alone should
constitute an indication for surgery. Because there
was no randomization to therapy, it is plausible that
many of the patients with increased AVC who did not
undergo surgery had a greater number of comorbid-
ities and/or a shorter life expectancy and were
considered high surgical risk. Thus, knowledge of
AVC may not have altered clinical decision making or
have changed the observed outcomes.
Meanwhile, until we have the answers to all of
these questions, many of us determining how to treat
the truly high-risk AS patient will remain stuck
between a rock and a hard place.
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